# NanoVibronix Inc. (NAOV)

Source: https://www.quantisnow.com/company/NAOV
Generated: 2026-11-18T23:56:01.094Z

- Ticker: NAOV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Industrial Specialties
- Website: nanovibronix.com

## About

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

## Latest NAOV news and filings

- 2026-02-24 13:30 UTC [ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera](https://www.quantisnow.com/insight/envue-medical-strengthens-patent-portfolio-with-new-uspto-notice-of-6409032)
- 2026-01-28 14:00 UTC [ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line](https://www.quantisnow.com/insight/envue-medical-signs-strategic-partnership-agreement-with-u-deliver-for-us-6363497)
- 2026-01-21 13:30 UTC [Leadership Update] [ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial](https://www.quantisnow.com/insight/envue-medical-appoints-industry-veteran-marc-waldman-as-vice-president-6355336)
- 2026-01-14 13:30 UTC [ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription](https://www.quantisnow.com/insight/envue-medical-launches-over-the-counter-reusable-enfit-syringes-to-support-feeding-6348927)
- 2026-01-09 14:01 UTC [ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research](https://www.quantisnow.com/insight/envue-medical-launches-program-to-address-patient-pain-and-discomfort-6344029)
- 2026-01-08 15:02 UTC [ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026](https://www.quantisnow.com/insight/envue-medical-to-ring-the-nasdaq-opening-bell-on-wednesday-6342623)
- 2025-12-18 22:40 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pionati Pellegrino](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pionati-pellegrino-6322720)
- 2025-12-18 22:36 UTC [SEC Form 3] [SEC Form 3 filed by new insider Johnson David Ian](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-johnson-david-ian-6322716)
- 2025-12-18 22:00 UTC [SEC Form 424B3] [SEC Form 424B3 filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-nanovibronix-inc-6322503)
- 2025-12-18 17:30 UTC [ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK](https://www.quantisnow.com/insight/envue-medical-formerly-nanovibronix-uroshield-kit-secures-reimbursement-in-the-6321768)
- 2025-12-18 14:00 UTC [ENvue Medical's UroShield® Kit Secures Reimbursement in the UK](https://www.quantisnow.com/insight/envue-medicals-uroshield-kit-secures-reimbursement-in-the-uk-6321526)
- 2025-12-12 14:06 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-amendments-to-articles-of-6313600)
- 2025-12-12 13:00 UTC [NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED'](https://www.quantisnow.com/insight/nanovibronix-inc-announces-name-and-ticker-symbol-change-to-envue-6313384)
- 2025-12-10 02:28 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-nanovibronix-inc-6309734)
- 2025-12-05 11:15 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-leadership-update-submission-of-6304284)
- 2025-11-19 13:00 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-regulation-fd-disclosure-6286270)
- 2025-11-19 13:00 UTC [NanoVibronix Issues Letter to Shareholders](https://www.quantisnow.com/insight/nanovibronix-issues-letter-to-shareholders-6286236)
- 2025-11-14 21:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-nanovibronix-inc-6280985)
- 2025-11-10 11:04 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-nanovibronix-inc-6269194)
- 2025-10-30 20:30 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-nanovibronix-inc-6252954)
- 2025-10-30 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-leadership-update-6252517)
- 2025-10-06 20:06 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-nanovibronix-inc-6224599)
- 2025-09-18 12:00 UTC [NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities](https://www.quantisnow.com/insight/nanovibronix-launches-oscar-training-aid-to-accelerate-envue-adoption-and-6204999)
- 2025-09-17 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-entry-into-a-material-6203947)
- 2025-09-17 16:11 UTC [SEC Form 424B5] [SEC Form 424B5 filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-nanovibronix-inc-6203711)
- 2025-09-16 19:57 UTC [Public Offering] [NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/nanovibronix-announces-pricing-of-20-million-registered-direct-offering-priced-6202340)
- 2025-09-15 21:10 UTC [SEC Form S-3] [SEC Form S-3 filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-nanovibronix-inc-6201275)
- 2025-09-15 12:00 UTC [NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio](https://www.quantisnow.com/insight/nanovibronix-announces-grant-of-new-us-patent-further-expanding-envue-6200327)
- 2025-09-04 12:00 UTC [NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology](https://www.quantisnow.com/insight/nanovibronix-announces-us-patent-granted-to-envue-medical-for-real-time-6189325)
- 2025-08-19 21:12 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-nanovibronix-inc-6172189)
- 2025-08-14 20:06 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Leadership Update](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-changes-in-registrants-certifying-6166067)
- 2025-08-14 20:05 UTC [SEC Form NT 10-Q filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-nanovibronix-inc-6165953)
- 2025-08-08 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-material-modification-to-rights-6156215)
- 2025-08-08 13:00 UTC [NanoVibronix Announces Reverse Stock Split](https://www.quantisnow.com/insight/nanovibronix-announces-reverse-stock-split-6155639)
- 2025-07-30 20:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by NanoVibronix Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-nanovibronix-inc-6138528)
- 2025-07-22 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-entry-into-a-material-6128237)
- 2025-07-18 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-submission-of-matters-to-6125438)
- 2025-07-18 13:00 UTC [NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock](https://www.quantisnow.com/insight/nanovibronix-announces-financing-of-up-to-50-million-private-placement-6125046)
- 2025-07-11 21:12 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-other-events-6118226)
- 2025-07-09 20:05 UTC [SEC Form 8-K] [NanoVibronix Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nanovibronix-inc-filed-sec-form-8-k-material-modification-to-rights-6115466)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NAOV
- Earnings history: https://www.quantisnow.com/earnings/NAOV
- Dividend history: https://www.quantisnow.com/dividends/NAOV
- Insider transactions: https://www.quantisnow.com/insiders/NAOV
- Options chain: https://www.quantisnow.com/options/NAOV
- SEC 8-K filings only: https://www.quantisnow.com/company/NAOV/8-k
- RSS and alerts for NAOV: https://www.quantisnow.com/docs/rss-feeds.md
